Abstract:Background: The identification of compound-protein interactions (CPIs) is crucial for drug discovery and understanding mechanisms of action. Accurate CPI prediction can elucidate drug-target-disease interactions, aiding in the discovery of candidate compounds and effective synergistic drugs, particularly from traditional Chinese medicine (TCM). Existing in silico methods face challenges in prediction accuracy and generalization due to compound and target diversity and the lack of largescale interaction datasets and negative datasets for model learning. Methods: To address these issues, we developed a computational model for CPI prediction by integrating the constructed large-scale bioactivity benchmark dataset with a deep learning (DL) algorithm. To verify the accuracy of our CPI model, we applied it to predict the targets of compounds in TCM. An herb pair of Astragalus membranaceus and Hedyotis diffusaas was used as a model, and the active compounds in this herb pair were collected from various public databases and the literature. The complete targets of these active compounds were predicted by the CPI model, resulting in an expanded target dataset. This dataset was next used for the prediction of synergistic antitumor compound combinations. The predicted multi-compound combinations were subsequently examined through in vitro cellular experiments. Results: Our CPI model demonstrated superior performance over other machine learning models, achieving an area under the Receiver Operating Characteristic curve (AUROC) of 0.98, an area under the precision-recall curve (AUPR) of 0.98, and an accuracy (ACC) of 93.31% on the test set. The model's generalization capability and applicability were further confirmed using external databases. Utilizing this model, we predicted the targets of compounds in the herb pair of Astragalus membranaceus and Hedyotis diffusaas, yielding an expanded target dataset. Then, we integrated this expanded target dataset to predict effective drug combinations using our drug synergy prediction model DeepMDS. Experimental assay on breast cancer cell line MDA-MB-231 proved the efficacy of the best predicted multi-compound combinations: Combination I (Epicatechin, Ursolic acid, Quercetin, Aesculetin and Astragaloside IV) exhibited a half-maximal inhibitory concentration (IC50) value of 19.41 μM, and a combination index (CI) value of 0.682; and Combination II (Epicatechin, Ursolic acid, Quercetin, Vanillic acid and Astragaloside IV) displayed a IC50 value of 23.83 μM and a CI value of 0.805. These results validated the ability of our model to make accurate predictions for novel CPI data outside the training dataset and evaluated the reliability of the predictions, showing good applicability potential in drug discovery and in the elucidation of the bioactive compounds in TCM. Conclusion: Our CPI prediction model can serve as a useful tool for accurately identifying potential CPI for a wide range of proteins, and is expected to facilitate drug research, repurposing and support the understanding of TCM.

Prediction of Chemical-Protein Interactions: Multitarget-Qsar Versus Computational Chemogenomic Methods

Prediction of Chemical-Protein Interactions Network with Weighted Network-Based Inference Method

MCPI: Integrating Multimodal Data for Enhanced Prediction of Compound Protein Interactions

A general prediction model for compound-protein interactions based on deep learning

AlzhCPI: A Knowledge Base for Predicting Chemical-Protein Interactions Towards Alzheimer’s Disease

A deep learning method for predicting molecular properties and compound-protein interactions

An Ensemble Learning-Based Method for Inferring Drug-Target Interactions Combining Protein Sequences and Drug Fingerprints

Computational Probing Protein-Protein Interactions Targeting Small Molecules.

Chemical-Protein Interactome and Its Application in Off-Target Identification

GraphCPIs: A novel graph-based computational model for potential compound-protein interactions

DPDR-CPI, a Server That Predicts Drug Positioning and Drug Repositioning Via Chemical-Protein Interactome

In-silico Target Prediction by Ensemble Chemogenomic Model Based on Multi-Scale Information of Chemical Structures and Protein Sequences.

Computational prediction of drug-target interactions using chemogenomic approaches: an empirical survey.

Discovery of Multitarget-Directed Ligands Against Alzheimer'S Disease Through Systematic Prediction of Chemical Protein Interactions

A Systematic Prediction Of Multiple Drug-Target Interactions From Chemical, Genomic, And Pharmacological Data

A Computational Approach For Predicting Drug-Target Interactions From Protein Sequence And Drug Substructure Fingerprint Information

A bidirectional interpretable compound-protein interaction prediction framework based on cross attention

Insights into performance evaluation of com-pound-protein interaction prediction methods

A Comparative Chemogenic Analysis for Predicting Drug-Target Pair Via Machine Learning Approaches.

Incorporating Chemical Sub-Structures and Protein Evolutionary Information for Inferring Drug-Target Interactions

ParaCPI: A Parallel Graph Convolutional Network for Compound-Protein Interaction Prediction